Activation of Nrf2 is protective in a model of LPS‐ and NF‐κB‐induced sepsis [126], which would further support the testing of DMF as an anti‐immunothrombotic agent, as TF‐driven thrombosis occurs via activation of NF‐κB. Here, NFKB1 is linked to Sepsis.